Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
McKesson
QuintilesIMS
AstraZeneca
Teva
UBS
Healthtrust
Medtronic

Generated: January 20, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: pemetrexed

« Back to Dashboard

pemetrexed Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
App Pharms pemetrexed 090384 1G INJECTABLE;INJECTION
Teva Pharms Usa pemetrexed sodium 090352 500MG INJECTABLE;INJECTION
App Pharms pemetrexed 090384 100MG INJECTABLE;INJECTION
Accord Hlthcare Inc pemetrexed disodium 203485 100MG INJECTABLE;INJECTION
Hospira Inc pemetrexed disodium 202111 500MG INJECTABLE;INJECTION
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Medtronic
Boehringer Ingelheim
Chinese Patent Office
AstraZeneca
US Army
Colorcon
Julphar
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.